Search Within

Neil Jayendra Shah

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
Groups
  1. Department of Medicine (17)
  2. Epidemiology and Biostatistics (17)
  3. Genitourinary Oncology Service (17)
  4. Solid Tumor Oncology Division (17)
  5. Hematologic Malignancies, Division of (15)
  6. Weinberg Fellows (15)

More Groups

People
  1. Ritesh Kotecha (11)
  2. David Aggen (10)
  3. Martin Voss (9)
  4. Robert Motzer (8)
  5. Chung-Han Lee (7)
  6. Darren Feldman (7)

More People

Years
  1. 2024 (7)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (1)
Publications
  1. Journal of Clinical Oncology (12)
  2. European Urology Oncology (2)
  3. Annals of Oncology (1)
  4. Cancer (1)
  5. Journal for ImmunoTherapy of Cancer (1)
Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier BV (2)
  3. Biomed Central Ltd (1)
  4. Oxford University Press (1)
  5. Wiley Blackwell (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Incidence and clinical outcomes of HER2-altered bladder cancer (BC) patients (pts)
    Meeting Abstract

    Lattanzi, M.; Niederhausern, A.; Zheng, J.; Bahadur, N.; Nichols, C.; Barton, L.; Gandhi, F.; Chan, K.; Insinga, A.; Philip, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing
    Journal Article

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Reisz, P. A.; Lenis, A. T.; Mehta, N. N.; Khurram, A.; Joseph, V.; Mandelker, D.; more...
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Real-time data quality assurance analysis for real-world, pan-cancer data
    Meeting Abstract

    Brown, S.; Lee, J.; Pillai, A.; Gandhi, F.; Bahadur, N.; Barton, L.; Chan, K.; Niederhausern, A.; Nichols, C.; Philip, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
    Journal Article

    Beattie, J.; Rizvi, H.; Fuentes, P.; Luo, J.; Schoenfeld, A.; Lin, I. H.; Postow, M.; Callahan, M.; Voss, M. H.; Shah, N. J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save